Drug Supply Chain Security Act (DSCSA)
The Drug Supply Chain Security Act (DSCSA), also known as Pharmaceutical Tracing, establishes a national system for tracing prescription drugs through the supply chain and sets national licensing standards to enhance the U.S. Food and Drug Administration’s (FDA) ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated or otherwise harmful. The DSCSA impacts all trading partners, including manufacturers, dispensers, repackagers and wholesale distributors.
Cardinal Health supports efforts to combat counterfeiting, contamination and adulteration of prescription drugs. We are continually working to provide our customers with the resources they need to ensure the drugs in the supply chain are safe.
Under DSCSA, we provide transaction data for eligible drugs online, 24x7, at no cost to customers. We also work closely with manufacturers to collect appropriate data and ensure their ongoing compliance with DSCSA in the most efficient manner possible. We take this responsibility seriously, as a safe and reliable drug supply is central to our customers’ business and critical to the health and well-being of consumers.
On November 27, 2023, as required under DSCSA, Cardinal Health will begin electronically tracking product at the individual package level using the manufacturer product identifier (2D barcode) that includes individual lot number and expiration date.
Visit the November 2023 DSCSA resource center to prepare for the enhanced requirements.